Skip to main content
. 2024 Jul 26;20(20):1385–1392. doi: 10.1080/14796694.2024.2351352

Figure 2.

Figure 2.

Time-to-treatment discontinuation in evaluable patients. No. of patients at risk: month 0, n = 110; month 12, n = 19; month 24, n = 5; month 36, n = 1; month 44, n = 0.